Stock 1612 VINCENT MEDICAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Vincent Medical Holdings Limited

Equities

1612

KYG9367D1025

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:42 28/06/2024 BST 		5-day change 1st Jan Change
0.425 HKD 0.00% Intraday chart for Vincent Medical Holdings Limited -1.16% +10.39%
05-22 Vincent Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2023 CI
03-21 Vincent Medical Swings to Profit in 2023 as Revenue Jumps 14% MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Its low valuation, with P/E ratio at 4.47 and 4.01 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The stock, which is currently worth 2024 to 0.13 times its sales, is clearly overvalued in comparison with peers.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The group usually releases upbeat results with huge surprise rates.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
VINCENT MEDICAL HOLDINGS LIMITED Stock Vincent Medical Holdings Limited
+10.39% 35.56M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.60% 181B
C+
MEDTRONIC PLC Stock Medtronic plc
-4.45% 101B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.15% 67.54B
A
DEXCOM, INC. Stock DexCom, Inc.
-8.63% 45.09B
B-
CENCORA, INC. Stock Cencora, Inc.
+9.70% 44.37B
B-
HOYA CORPORATION Stock Hoya Corporation
+6.13% 40.7B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.22% 29.85B
B
TERUMO CORPORATION Stock Terumo Corporation
+14.80% 24.49B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.46% 23.99B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
-
  1. Stock Market
  2. Equities
  3. 1612 Stock
  4. Ratings Vincent Medical Holdings Limited